Skip to main content
Caplight Logo









Adipo Therapeutics

Adipo Therapeutics

Private
Indianapolis, IndianaHealthcare & Life Scienceshttps://adipotherapeutics.com/

Last Round

Series A

May 9, 2025

Total Funding Raised

$6.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Adipo Therapeutics is a biotechnology company developing a novel therapeutic platform that uses Notch-inhibiting nanoparticles to convert energy-storing white fat into energy-burning brown fat for the treatment of obesity and Type 2 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanoparticle drug deliveryobesity treatmentmetabolic diseaseadipose browningType 2 diabetesfat burnerbiopharmaceuticalNotch pathway inhibitorweight loss drugbiodegradable polymermetabolic healthpreclinical biotechdrug discoveryprecision medicineGLP-1 alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adipo Therapeutics Comparables

Compare Adipo Therapeutics with similar companies based on industry and business-model similarity.

Adipo Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Equator Therapeutics
85%
Energesis Pharmaceuticals, Inc.
83%
Cyta Therapeutics
81%

Adipo Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 9, 2025
GrantJun 24, 2024
SeedJan 31, 2024
SeedApr 11, 2023
SeedJan 11, 2022
Grant
Sep 13, 2018

Key People

Founding team and executive leadership

Karen Wurster

Chief Executive Officer

Executive Team

Keith Johns

Chief Operating Officer (CSO)

Executive Team

Adipo Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 51% MoM, reaching 2.2K.

  • Jul 28, 2026

    Monthly visitors increased 123% MoM, reaching 1.5K.

Adipo Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Adipo Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adipo Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersIndianapolis, Indiana
Employee Range6
Year Founded2016
Last FundingMay 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?